National

Bharat Biotech’s COVID-19 vaccine for kids gets DCGI nod for Emergency Use

The Drug Controller General of India (DGCI) gave Bharat Biotech approval for emergency use authorisation of the Covaxin COVID-19 vaccine for children in the 12-18 years age group on Saturday.

This makes Covaxin the second vaccine cleared for use for children in India.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button